The FDA has issued a CRL to Otsuka and Lundbeck regarding the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD.
Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point ...
Nikita Blake, 32, argued her history of depression and abuse should mean she avoided jail for drunkenly waving a knife but a ...
A top veterans organization has entered a first-of-its-kind partnership with a hemp THC beverage company, with a licensing ...
In 2023, an estimated 11.4% of adult Americans took antidepressants. Here's how the class of medication can help depression ...
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA’s advancing programs ...
New York may be on the verge of becoming the next state to legalize psilocybin, the active ingredient in psychedelic ...
Friends, family members and acquaintances of accused killer Michael Brown of Anaconda say his persistent delusions included ...
Music mogul Sean "Diddy" Combs will learn Friday how long he will serve in prison for transporting prostitutes across state ...
Australia’s largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSD ...
By David Larson Carolina Journal Once you see it, it’s hard not to keep seeing it. In case after case of recent high-profile violence, the perpetrators were described as experiencing serious mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback